[Guidelines for the diagnosis and treatment of H. pylori infection].
D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004381:Duodenal Ulcer / Q000517:prevention & control; D004415:Dyspepsia / Q000517:prevention & control; D005757:Gastritis, Atrophic; D005764:Gastroesophageal Reflux / Q000517:prevention & control; D016481:Helicobacter Infections / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D016480:Helicobacter pylori; D006801:Humans; D018442:Lymphoma, B-Cell, Marginal Zone / Q000517:prevention & control; D008795:Metronidazole / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D054328:Proton Pump Inhibitors; D012307:Risk Factors; D013274:Stomach Neoplasms / Q000517:prevention & control; D013276:Stomach Ulcer / Q000209:etiology / Q000517:prevention & control; D013997:Time Factors
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D054328:Proton Pump Inhibitors; D008795:Metronidazole
Leitlinien zur Diagnostik und Therapie der H.-pylori-Infektion. Wen testen, wann und wie eradizieren?